Clin2
NCT07838311Possibly a fitNot yet recruiting

ADHD medication for young people with cannabis use

ADHDCannabis Use Disorder

Part of Mental health clinical trials.

This study tests whether a long-acting ADHD medication called methylphenidate (Jornay PM) can help young people with both ADHD and cannabis use disorder reduce their cannabis use. It aims to see if treating ADHD symptoms also helps with cannabis problems.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
66 people
Ages
16 years to 26 years
Study type
Interventional

Who can take part

  • You must be between 16 and 26 years old
  • You must live in Massachusetts
  • You must have a diagnosis of ADHD and cannabis use disorder
  • You must have used cannabis at least 3 days in the past week
  • You must be interested in or already getting treatment for cannabis use
  • You must be able to swallow large capsules and not be allergic to methylphenidate

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06661031Enrolling by invitation
Cannabis use help for young adults via phone app

This study tests a new program that combines telehealth coaching and a smartphone app to help young adults who use cannabis a lot to cut back or quit. If you are a patient at certain Boston clinics and use cannabis on most days, this study might be a good fit for you.

Boston, Massachusetts
NCT07650643Not yet recruiting· Phase 4
Brain wave test to guide ADHD medication choice

This study tests whether brain wave recordings (EEG) can help predict how well children with ADHD will respond to stimulant medications. It aims to find the best treatment faster, potentially reducing the guesswork in choosing the right medication.

Brookline, Massachusetts
NCT05957848Recruiting· Phase 2
Guanfacine for teens with cannabis use problems

This Phase 2 study tests whether extended-release guanfacine can reduce cannabis use in adolescents and young adults. It may help by targeting brain pathways that can drive cravings or continued use.

Parkville, Victoria
NCT05859347Recruiting
Brain stimulation study for cannabis use disorder

This trial tests whether a treatment called repetitive transcranial magnetic stimulation (a non-surgical magnetic stimulation to the brain) can help people reduce or stop cannabis use. You may be eligible if you have cannabis use disorder and meet specific safety and symptom criteria.

Toronto, Ontario
NCT07634835Not yet recruiting
Brain stimulation for teens and young adults with cannabis use disorder

This trial tests whether a painless brain stimulation treatment called transcranial magnetic stimulation (TMS) can help teens and young adults reduce their cannabis use. The treatment uses magnetic pulses to target parts of the brain involved in cravings and self-control.

Minneapolis, Minnesota
NCT06569394Recruiting· Phase 2
Testing CBD in young adults who use cannabis heavily

This study tests whether cannabidiol (CBD) can help young adults who use cannabis heavily but aren't looking to quit. You'll take a CBD pill and see if it changes your cannabis use or related symptoms.

Aurora, Colorado

Hear when a new Cannabis Use Disorder trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.